Vera Therapeutics IncNASDAQ:VERA
- LAST PRICE35.6300
- TODAY'S CHANGE (%)0.7400 (2.1210%)
- Bid / Lots33.8800/ 1
- Ask / Lots35.8100/ 2
- Open / Previous Close34.9000 / 34.8900
- Day Range
- 52 Week Range
- Volume270,594
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VERA |
|---|---|---|
| 09:32 ET | 9818 | 34.43 |
| 09:34 ET | 382 | 33.97 |
| 09:36 ET | 3312 | 34.54 |
| 09:38 ET | 200 | 34.48 |
| 09:39 ET | 100 | 34.675 |
| 09:45 ET | 100 | 34.635 |
| 09:50 ET | 300 | 34.59 |
| 09:52 ET | 1000 | 34.75 |
| 09:54 ET | 4900 | 34.5 |
| 09:56 ET | 3044 | 34.5 |
| 09:57 ET | 942 | 34.5 |
| 09:59 ET | 200 | 34.57 |
| 10:01 ET | 412 | 34.5 |
| 10:03 ET | 968 | 34.48 |
| 10:06 ET | 300 | 34.4 |
| 10:08 ET | 1387 | 34.51 |
| 10:10 ET | 416 | 34.555 |
| 10:12 ET | 223 | 34.52 |
| 10:17 ET | 1583 | 34.7 |
| 10:28 ET | 1328 | 34.7 |
| 10:32 ET | 781 | 34.75 |
| 10:35 ET | 150 | 34.722 |
| 10:37 ET | 300 | 34.67 |
| 10:44 ET | 1395 | 34.75 |
| 10:46 ET | 1120 | 34.9 |
| 10:50 ET | 342 | 34.77 |
| 10:51 ET | 200 | 34.8 |
| 10:53 ET | 200 | 34.88 |
| 11:02 ET | 100 | 34.82 |
| 11:04 ET | 100 | 34.78 |
| 11:06 ET | 1400 | 35.01 |
| 11:08 ET | 1617 | 35.01 |
| 11:11 ET | 300 | 35.01 |
| 11:15 ET | 1000 | 35.155 |
| 11:20 ET | 100 | 35.23 |
| 11:22 ET | 200 | 35.23 |
| 11:24 ET | 637 | 35.13 |
| 11:26 ET | 300 | 35.16 |
| 11:31 ET | 900 | 35.39 |
| 11:36 ET | 200 | 35.43 |
| 11:40 ET | 700 | 35.43 |
| 11:45 ET | 1461 | 35.46 |
| 11:47 ET | 100 | 35.425 |
| 11:49 ET | 300 | 35.45 |
| 11:51 ET | 2898 | 35.435 |
| 11:54 ET | 600 | 35.425 |
| 11:56 ET | 400 | 35.46 |
| 11:58 ET | 300 | 35.42 |
| 12:00 ET | 2759 | 35.7 |
| 12:02 ET | 1200 | 35.5 |
| 12:03 ET | 100 | 35.59 |
| 12:05 ET | 100 | 35.53 |
| 12:09 ET | 100 | 35.54 |
| 12:14 ET | 440 | 35.59 |
| 12:16 ET | 100 | 35.61 |
| 12:18 ET | 100 | 35.6 |
| 12:20 ET | 200 | 35.69 |
| 12:21 ET | 100 | 35.63 |
| 12:23 ET | 100 | 35.74 |
| 12:25 ET | 100 | 35.63 |
| 12:30 ET | 100 | 35.63 |
| 12:32 ET | 100 | 35.665 |
| 12:34 ET | 1567 | 35.51 |
| 12:36 ET | 1737 | 35.63 |
| 12:38 ET | 200 | 35.56 |
| 12:39 ET | 200 | 35.55 |
| 12:41 ET | 100 | 35.54 |
| 12:43 ET | 1000 | 35.655 |
| 12:48 ET | 300 | 35.56 |
| 12:50 ET | 100 | 35.56 |
| 12:52 ET | 100 | 35.56 |
| 12:54 ET | 1300 | 35.54 |
| 12:56 ET | 600 | 35.48 |
| 12:57 ET | 100 | 35.45 |
| 01:01 ET | 100 | 35.525 |
| 01:03 ET | 100 | 35.49 |
| 01:06 ET | 200 | 35.595 |
| 01:08 ET | 100 | 35.51 |
| 01:12 ET | 100 | 35.49 |
| 01:15 ET | 100 | 35.51 |
| 01:17 ET | 2690 | 35.3 |
| 01:21 ET | 300 | 35.355 |
| 01:24 ET | 200 | 35.33 |
| 01:26 ET | 600 | 35.45 |
| 01:30 ET | 100 | 35.41 |
| 01:33 ET | 500 | 35.45 |
| 01:35 ET | 121 | 35.36 |
| 01:39 ET | 376 | 35.356 |
| 01:42 ET | 400 | 35.36 |
| 01:44 ET | 100 | 35.445 |
| 01:46 ET | 200 | 35.39 |
| 01:50 ET | 200 | 35.39 |
| 01:51 ET | 100 | 35.39 |
| 01:53 ET | 1100 | 35.34 |
| 01:57 ET | 256 | 35.41 |
| 02:00 ET | 100 | 35.39 |
| 02:04 ET | 200 | 35.4 |
| 02:06 ET | 200 | 35.36 |
| 02:08 ET | 100 | 35.36 |
| 02:09 ET | 100 | 35.415 |
| 02:11 ET | 100 | 35.36 |
| 02:13 ET | 100 | 35.435 |
| 02:15 ET | 400 | 35.32 |
| 02:20 ET | 100 | 35.35 |
| 02:24 ET | 100 | 35.35 |
| 02:27 ET | 100 | 35.4 |
| 02:29 ET | 400 | 35.415 |
| 02:31 ET | 100 | 35.415 |
| 02:33 ET | 300 | 35.48 |
| 02:36 ET | 1277 | 35.42 |
| 02:40 ET | 200 | 35.41 |
| 02:42 ET | 500 | 35.35 |
| 02:44 ET | 100 | 35.375 |
| 02:45 ET | 100 | 35.33 |
| 02:49 ET | 100 | 35.32 |
| 02:51 ET | 100 | 35.365 |
| 02:58 ET | 300 | 35.32 |
| 03:00 ET | 2000 | 35.21 |
| 03:02 ET | 100 | 35.21 |
| 03:05 ET | 1213 | 35.23 |
| 03:07 ET | 5110 | 35.32 |
| 03:09 ET | 2200 | 35.35 |
| 03:12 ET | 600 | 35.465 |
| 03:14 ET | 100 | 35.46 |
| 03:16 ET | 200 | 35.46 |
| 03:18 ET | 730 | 35.37 |
| 03:23 ET | 200 | 35.385 |
| 03:25 ET | 3199 | 35.34 |
| 03:27 ET | 1000 | 35.29 |
| 03:30 ET | 1300 | 35.29 |
| 03:32 ET | 400 | 35.29 |
| 03:36 ET | 200 | 35.25 |
| 03:38 ET | 500 | 35.3 |
| 03:39 ET | 6770 | 35.545 |
| 03:41 ET | 1754 | 35.77 |
| 03:43 ET | 2410 | 35.715 |
| 03:45 ET | 483 | 35.67 |
| 03:48 ET | 3141 | 35.51 |
| 03:50 ET | 1350 | 35.58 |
| 03:52 ET | 5202 | 35.52 |
| 03:54 ET | 2000 | 35.52 |
| 03:56 ET | 4014 | 35.565 |
| 03:57 ET | 2581 | 35.54 |
| 03:59 ET | 53462 | 35.63 |
Jul 5, 2024
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:30PM ET on Friday Jul 05, 2024 by Dow Jones
4:30PM ET on Friday Jul 05, 2024 by Dow Jones
Jul 1, 2024
Vera Therapeutics Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Officer, from 8:00AM ET on Monday Jul 01, 2024 by Dow Jones
8:00AM ET on Monday Jul 01, 2024 by Dow JonesPress Release: Vera Therapeutics Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Officer, from 8:00AM ET on Monday Jul 01, 2024 by Dow Jones
8:00AM ET on Monday Jul 01, 2024 by Dow Jones
Jun 11, 2024
Press Release: Vera Therapeutics Appoints Christy J. Oliger to Board of Directors, from 4:01PM ET on Tuesday Jun 11, 2024 by Dow Jones
4:01PM ET on Tuesday Jun 11, 2024 by Dow JonesVera Therapeutics Appoints Christy J. Oliger to Board of Directors, from 4:01PM ET on Tuesday Jun 11, 2024 by Dow Jones
4:01PM ET on Tuesday Jun 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vera Therapeutics Inc | 1.9B | -17.4x | --- |
Rocket Pharmaceuticals Inc | 1.8B | -7.0x | --- |
Janux Therapeutics Inc | 2.1B | -32.6x | --- |
CG Oncology Inc | 2.1B | -28.3x | --- |
Iovance Biotherapeutics Inc | 2.0B | -4.0x | --- |
Edgewise Therapeutics Inc | 1.8B | -12.7x | --- |
Company Information
Vera Therapeutics, Inc. is a late-stage biotechnology company. The Company is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Its product candidate, atacicept, is a self-administered fusion protein that blocks both a B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL) which stimulates B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. The Company is also engaged in developing MAU868, a monoclonal antibody designed to neutralize infection with BK Virus, a polyomavirus that can have devastating consequences in certain settings such as kidney transplants. The Company is conducting a randomized, double-blind, placebo-controlled Phase 3 clinical trial in IgAN, which it refers to as ORIGIN 3, and completing the open label extension of its Phase 2b clinical trial in IgAN, which it refers to as ORIGIN 2b.
Contact Information
- Headquarters
- 8000 Marina Boulevard,, Suite 120BRISBANE, CA, United States 94005
- Phone
- 650-770-0077
- Fax
- 302-655-5049
Executives
- Independent Non-Executive Chairman of the Board
- Michael Morrissey
- President, Chief Executive Officer, Founder, Director
- Marshall Fordyce
- Chief Financial Officer
- Sean Grant
- Chief Operating Officer
- David Johnson
- Chief Medical Officer
- Robert Brenner
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.9B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 54.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.04 |
Book Value | $2.29 |
P/E Ratio | -17.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
